Trials / Completed
CompletedNCT03622450
The Effect of Colistin Inhalation on Ventilator Associated Pneumonia
The Effect of Colistin Inhalation on the Clinical Outcome of Patients With Ventilator Associated Pneumonia
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Nourhan Hassan Osama Thuraya Mohamed · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study has been conducted to measure the clinical outcome of early intervention with colistin inhalation in patients with ventilator associated pneumonia suspected to have multidrug resistant gram -ve bacteria
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Colistin | Polymyxins are bactericidal drugs that bind to lipopolysaccharides (LPS) and phospholipids in the outer cell membrane of gram-negative bacteria. |
| DRUG | Carbapenem + Aminoglycoside/ Quinolone | Dual antipseudomonal given as IV for ventilator associated pneumonia for patients with Multi-drug resistant bacteria risk factors |
Timeline
- Start date
- 2016-01-02
- Primary completion
- 2018-01-06
- Completion
- 2018-01-10
- First posted
- 2018-08-09
- Last updated
- 2018-08-09
Source: ClinicalTrials.gov record NCT03622450. Inclusion in this directory is not an endorsement.